Elena S. Ovsyankina
Research Subjects
Elena S. Ovsyankina has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
- Lyudmila V. Panova
Central Research Institute of Tuberculosis of the Ministry of Science and Higher Education of the Russian Federation
24 shared publications - Irina N. Zakharova
Russian Medical Academy of Continuous Professional Education
6 shared publications - Mikhail Mikhailovich Averbakh
Central Tuberculosis Research Institute
5 shared publications - A. Yu. Khiteva
Central Research Institute of Tuberculosis
3 shared publications - E. A. Krushinskaya
Central Tuberculosis Research Institute
3 shared publications - Elena Ivanovna Kondratieva
Research Centre for Medical Genetics, Moscow 115522, Russia
3 shared publications
Latest Publications
- Open Access
- 30 April 2026
- Published by Publishing House OKI in Antibiot Khimioter = Antibiotics and Chemotherapy
- Vol. 71 (3-4) , 16-24
The Effectiveness of Delamanid in Short-Course Chemotherapy Regimens for Drug-Resistant Tuberculosis in Children and Adolescents
Background . The development of short, safe, and effective chemotherapy regimens for drug-resistant tuberculosis in children and adolescents — based on the introduction of new drugs — remains a pressing issue. The aim of the study was to evaluate the effectiveness and safety of short-course chemotherapy regimens incorporating delamanid (Dlm) in children and adolescents with tuberculosis caused by multidrug-resistant, pre-extensively drug-resistant, or extensively drug-resistant (MDR/pre-XDR/XDR) strains. Materials and Methods . A prospective, open-label, non-comparative study has been conducted since March 2022. The study enrolled 37 patients (aged 2–17 years) with various forms of respiratory tuberculosis who received Dlm in combination with a standard regimen consisting of at least three drugs. The primary efficacy analysis was performed upon completion of the main course of chemotherapy, involving an assessment of treatment outcomes; the secondary analysis consisted of a follow-up visit at one year to monitor for tuberculosis recurrence. The assessment of Dlm tolerability was based on: cardiotoxic reactions (ECG monitoring); neuropsychiatric reactions (patient interviews, observation of behaviour and sleep). Results . The treatment outcome recorded was «clinically cured» for 100% of patients across all age groups. Short-course chemotherapy regimens were administered to 83.0% (29/35) of patients (70.4–95.3%, 95% CI). Of the 29 patients treated with short-course regimens: 3 received a 6-month regimen, 9 received a 9-month regimen, and 17 received a 12-month regimen. Follow-up was conducted one year after the completion of shortcourse treatment regimens in 16 patients; no relapses were detected. An association between the administration of Dlm and the development of adverse reactions was established in 8% (3/37) of cases — specifically, neuropsychiatric adverse reactions. Conclusion . The use of Dlm in combination with other drugs within short-course chemotherapy regimens for tuberculosis — specifically, cases involving MDR, pre-XDR, or XDR Mycobacterium tuberculosis — demonstrates a high success rate when administered as part of a comprehensive treatment strategy.
- 30 April 2026
- Published by Publishing House OKI in Antibiot Khimioter = Antibiotics and Chemotherapy
- Vol. 71 (3-4) , 16-24
Open AccessThe Effectiveness of Delamanid in Short-Course Chemotherapy Regimens for Drug-Resistant Tuberculosis in Children and Adolescents
Background . The development of short, safe, and effective chemotherapy regimens for drug-resistant tuberculosis in children and adolescents — based on the introduction of new drugs — remains a pressing issue. The aim of the study was to evaluate the effectiveness and safety of short-course chemotherapy regimens incorporating delamanid (Dlm) in children and adolescents with tuberculosis caused by multidrug-resistant, pre-extensively drug-resistant, or extensively drug-resistant (MDR/pre-XDR/XDR) strains. Materials and Methods . A prospective, open-label, non-comparative study has been conducted since March 2022. The study enrolled 37 patients (aged 2–17 years) with various forms of respiratory tuberculosis who received Dlm in combination with a standard regimen consisting of at least three drugs. The primary efficacy analysis was performed upon completion of the main course of chemotherapy, involving an assessment of treatment outcomes; the secondary analysis consisted of a follow-up visit at one year to monitor for tuberculosis recurrence. The assessment of Dlm tolerability was based on: cardiotoxic reactions (ECG monitoring); neuropsychiatric reactions (patient interviews, observation of behaviour and sleep). Results . The treatment outcome recorded was «clinically cured» for 100% of patients across all age groups. Short-course chemotherapy regimens were administered to 83.0% (29/35) of patients (70.4–95.3%, 95% CI). Of the 29 patients treated with short-course regimens: 3 received a 6-month regimen, 9 received a 9-month regimen, and 17 received a 12-month regimen. Follow-up was conducted one year after the completion of shortcourse treatment regimens in 16 patients; no relapses were detected. An association between the administration of Dlm and the development of adverse reactions was established in 8% (3/37) of cases — specifically, neuropsychiatric adverse reactions. Conclusion . The use of Dlm in combination with other drugs within short-course chemotherapy regimens for tuberculosis — specifically, cases involving MDR, pre-XDR, or XDR Mycobacterium tuberculosis — demonstrates a high success rate when administered as part of a comprehensive treatment strategy.
- 17 April 2026
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 36 (2)
The first experience of using bedaquiline in the treatment of pulmonary mycobacteriosis in children with cystic fibrosis
Patients with cystic fibrosis (CF) have the highest risk of developing pulmonary mycobacteriosis. A pressing issue is the introduction of new drugs, such as bedaquiline, into pediatric clinical practice, as these drugs have shown proven efficacy against nontuberculous mycobacteria (NTM) in microbiological studies. The aim of this study was to demonstrate the first experience of using bedaquiline in the treatment of pulmonary mycobacteriosis in two 14-year-old boys with CF. Conclusion. Clinical, laboratory, and radiographic tests demonstrated the efficacy of bedaquiline when included in mycobacteriosis treatment regimens. A good tolerability was noted. Persistent isolation of Mycobacterium abscessus after 12 months of treatment in case 1 and M. intracellulare after 6 months in case 2 were considered carrier states. The use of bedaquiline did not result in the expected eradication of NTM, confirming the need for continued research and the search for new drugs for the treatment of pulmonary mycobacteriosis in patients with CF and implementation of these drugs into clinical practice.
- 17 April 2026
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 36 (2)
The first experience of using bedaquiline in the treatment of pulmonary mycobacteriosis in children with cystic fibrosis
Patients with cystic fibrosis (CF) have the highest risk of developing pulmonary mycobacteriosis. A pressing issue is the introduction of new drugs, such as bedaquiline, into pediatric clinical practice, as these drugs have shown proven efficacy against nontuberculous mycobacteria (NTM) in microbiological studies. The aim of this study was to demonstrate the first experience of using bedaquiline in the treatment of pulmonary mycobacteriosis in two 14-year-old boys with CF. Conclusion. Clinical, laboratory, and radiographic tests demonstrated the efficacy of bedaquiline when included in mycobacteriosis treatment regimens. A good tolerability was noted. Persistent isolation of Mycobacterium abscessus after 12 months of treatment in case 1 and M. intracellulare after 6 months in case 2 were considered carrier states. The use of bedaquiline did not result in the expected eradication of NTM, confirming the need for continued research and the search for new drugs for the treatment of pulmonary mycobacteriosis in patients with CF and implementation of these drugs into clinical practice.
- Open Access
- 24 March 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 159-166
Latent tuberculosis infection in interdisciplinary aspects of diagnosis of tuberculosis (phthisiologist’s review and comments)
Massive proportion of world’s population (nearly 1/3 of mankind, according to the WHO estimates) have latent tuberculosis infection (LTBI). Persons with LTBI are not ill and not infectious to those around them, but the lifetime risk of developing active TB is 5–20% among infected persons, with the majority developing TB disease within 2–5 years after infection. LTBI is a reservoir for future TB cases, and without control over it, all efforts to fight against TB will be brought down to a minimum. This issue is the most pressing one in the pediatric practice, as the main mass methods for detecting LTBI now are immunological TB tests, which are used in children’s primary care facilities on a mass scale. The objective of this review is determined by the necessity to improve knowledge regarding latent tuberculosis infection in children and adolescents as a predictor of the local tuberculosis for the timely formation of groups at high risk of exposure to TB disease and arrangement of preventive measures. 27 articles have been selected for screening during the search process according to the key words after removal of dublicates in the databases. The paper presents new guiding documents, phthisiologist’s comments taking into account interdisciplinary interaction on the issues of screening and monitoring of TB to identify individuals with LTBI. The importance of skin tests as screening methods remains indisputable, given a certain preference for high sensitivity of test results over their specificity. Mantoux skin tests using 2 tuberculin units (TU) of purified protein derivative (PPD)-L and a test with recombinant tuberculosis allergen (RTA) due to their high sensitivity, simplicity and cost effectiveness are the most preferred diagnostic tools for detecting LTBI, which are perfectly suited for mass screening of population. Laboratory diagnostic tests assessing release of interferon gamma in vitro by T-lymphocytes (IGRA-tests) are presented. The results of these tests can be considered when conducting routine tuberculosis screening.
- 24 March 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 159-166
Open AccessLatent tuberculosis infection in interdisciplinary aspects of diagnosis of tuberculosis (phthisiologist’s review and comments)
Massive proportion of world’s population (nearly 1/3 of mankind, according to the WHO estimates) have latent tuberculosis infection (LTBI). Persons with LTBI are not ill and not infectious to those around them, but the lifetime risk of developing active TB is 5–20% among infected persons, with the majority developing TB disease within 2–5 years after infection. LTBI is a reservoir for future TB cases, and without control over it, all efforts to fight against TB will be brought down to a minimum. This issue is the most pressing one in the pediatric practice, as the main mass methods for detecting LTBI now are immunological TB tests, which are used in children’s primary care facilities on a mass scale. The objective of this review is determined by the necessity to improve knowledge regarding latent tuberculosis infection in children and adolescents as a predictor of the local tuberculosis for the timely formation of groups at high risk of exposure to TB disease and arrangement of preventive measures. 27 articles have been selected for screening during the search process according to the key words after removal of dublicates in the databases. The paper presents new guiding documents, phthisiologist’s comments taking into account interdisciplinary interaction on the issues of screening and monitoring of TB to identify individuals with LTBI. The importance of skin tests as screening methods remains indisputable, given a certain preference for high sensitivity of test results over their specificity. Mantoux skin tests using 2 tuberculin units (TU) of purified protein derivative (PPD)-L and a test with recombinant tuberculosis allergen (RTA) due to their high sensitivity, simplicity and cost effectiveness are the most preferred diagnostic tools for detecting LTBI, which are perfectly suited for mass screening of population. Laboratory diagnostic tests assessing release of interferon gamma in vitro by T-lymphocytes (IGRA-tests) are presented. The results of these tests can be considered when conducting routine tuberculosis screening.
- Open Access
- 12 October 2025
- Published by Publishing House OKI in Antibiot Khimioter = Antibiotics and Chemotherapy
- Vol. 70 (5-6) , 21-26
Tolerability of Linezolid in Individualized Chemotherapy Regimens for Adolescents with Multi- or Pre-Extensively Drug-Resistant Tuberculosis
Background. The effectiveness of treatment for multidrug-resistant (MDR)/pre-extensively drug-resistant (pre-XDR) TB directly depends on the tolerability of chemotherapy, including linezolid, a group A drug. Aim: To study the incidence and types of adverse drug reactions (ADRs) to linezolid and ways to improve them in adolescents with MDR/pre-XDR TB. Methods. A retrospective study included 38 patients aged 13–17 years with various forms of pulmonary TB: MDR TB — 52.6 %, pre-XDR TB — 42.1 %, XDR TB — 5.3 %. The levels of eosinophils, hemoglobin, erythrocytes, leukocytes; ALT, AST were assessed. The immunological study (lymphocyte blast-transformation reaction) was performed to evaluate linezolid tolerability. ADRs were assessed by type (allergic, toxic, toxicoallergic) and severity. Results. The development of ADRs to linezolid was registered in 34.2 % of cases with prevailing toxic reactions (76.9 %). The most frequent reaction was anemia (46.2 %), ADRs of severity levels 1–2 were registered in 80 % of cases. ADRs were immunologically confirmed in 30.8 % of thecases — in patients with allergic, as well as both toxic and allergic reactions. In 84.6% of cases, short-term withdrawal of linezolid and symptomatic treatment were required. Conclusion. Despite the high frequency of ADRs induced by linezolid administration, most of them were mild and could be corrected without long-term drug withdrawal.
- 12 October 2025
- Published by Publishing House OKI in Antibiot Khimioter = Antibiotics and Chemotherapy
- Vol. 70 (5-6) , 21-26
Open AccessTolerability of Linezolid in Individualized Chemotherapy Regimens for Adolescents with Multi- or Pre-Extensively Drug-Resistant Tuberculosis
Background. The effectiveness of treatment for multidrug-resistant (MDR)/pre-extensively drug-resistant (pre-XDR) TB directly depends on the tolerability of chemotherapy, including linezolid, a group A drug. Aim: To study the incidence and types of adverse drug reactions (ADRs) to linezolid and ways to improve them in adolescents with MDR/pre-XDR TB. Methods. A retrospective study included 38 patients aged 13–17 years with various forms of pulmonary TB: MDR TB — 52.6 %, pre-XDR TB — 42.1 %, XDR TB — 5.3 %. The levels of eosinophils, hemoglobin, erythrocytes, leukocytes; ALT, AST were assessed. The immunological study (lymphocyte blast-transformation reaction) was performed to evaluate linezolid tolerability. ADRs were assessed by type (allergic, toxic, toxicoallergic) and severity. Results. The development of ADRs to linezolid was registered in 34.2 % of cases with prevailing toxic reactions (76.9 %). The most frequent reaction was anemia (46.2 %), ADRs of severity levels 1–2 were registered in 80 % of cases. ADRs were immunologically confirmed in 30.8 % of thecases — in patients with allergic, as well as both toxic and allergic reactions. In 84.6% of cases, short-term withdrawal of linezolid and symptomatic treatment were required. Conclusion. Despite the high frequency of ADRs induced by linezolid administration, most of them were mild and could be corrected without long-term drug withdrawal.
- Open Access
- 2 August 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 11,p. 144-150
Contact of adolescents with a TB patient: acute issues according to the specialist hospital
Introduction. Any contact with a TB patient is the leading risk factor for developing TB disease in children and adolescents, and availability of a family/close relative contact matters the most for its realization. TB foci with multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis (MDR/XDR MBT) strains that are present at the source of infection require special attention as the most epidemically dangerous ones.Aim. To identify the major reasons for the development and late diagnosis of TB disease in adolescents from the infection foci, and to find possible ways to address identified issues.Materials and methods. A retrospective cohort study (2021 to 2023) was conducted. 90 medical records of adolescents were analysed. In 53 cases, contacts with a TB patient were identified (58.9%). The statistical relationship between the studied risk factors that could affect the late detection of the TB disease was calculated using the Pearson χ2 test.Results. It has been established that a lack of proper follow-up medical care over exposed persons at the tuberculosis dispensary (TBD) (violations of the procedures for follow-up checkups, preventive chemotherapy) and missed opportunities in mass screening in the primary health care (PHC) facilities are the main reasons for late detection of the disease, especially when several risk factors are combined, and clinical signs of the disease are present. TB screening methods applied at the infection foci have proven to be most effective when implemented on a regular basis. The disease can manifest during long intervals between medical checkups in the absence of pronounced clinical symptoms of the disease and in a torpid course, which identifies inconsistency between TB diagnostic techniques (screening) and its clinical form (widespread, complicated processes).Conclusion. To solve this issue, the following measures are required: mandatory follow-ups of exposed persons at the TBD regardless of legal representative / patient’s wishes; determination of the conditions for isolation of a source of infection from a contact adolescent until bacterial excretion is completed; personalized follow-up care and thorough medical checkups of exposed persons, if MDR/XDR MBT strains are identified at the source of infection; improvement of interdisciplinary collaboration between primary health care facilities.
- 2 August 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 11,p. 144-150
Open AccessContact of adolescents with a TB patient: acute issues according to the specialist hospital
Introduction. Any contact with a TB patient is the leading risk factor for developing TB disease in children and adolescents, and availability of a family/close relative contact matters the most for its realization. TB foci with multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis (MDR/XDR MBT) strains that are present at the source of infection require special attention as the most epidemically dangerous ones.Aim. To identify the major reasons for the development and late diagnosis of TB disease in adolescents from the infection foci, and to find possible ways to address identified issues.Materials and methods. A retrospective cohort study (2021 to 2023) was conducted. 90 medical records of adolescents were analysed. In 53 cases, contacts with a TB patient were identified (58.9%). The statistical relationship between the studied risk factors that could affect the late detection of the TB disease was calculated using the Pearson χ2 test.Results. It has been established that a lack of proper follow-up medical care over exposed persons at the tuberculosis dispensary (TBD) (violations of the procedures for follow-up checkups, preventive chemotherapy) and missed opportunities in mass screening in the primary health care (PHC) facilities are the main reasons for late detection of the disease, especially when several risk factors are combined, and clinical signs of the disease are present. TB screening methods applied at the infection foci have proven to be most effective when implemented on a regular basis. The disease can manifest during long intervals between medical checkups in the absence of pronounced clinical symptoms of the disease and in a torpid course, which identifies inconsistency between TB diagnostic techniques (screening) and its clinical form (widespread, complicated processes).Conclusion. To solve this issue, the following measures are required: mandatory follow-ups of exposed persons at the TBD regardless of legal representative / patient’s wishes; determination of the conditions for isolation of a source of infection from a contact adolescent until bacterial excretion is completed; personalized follow-up care and thorough medical checkups of exposed persons, if MDR/XDR MBT strains are identified at the source of infection; improvement of interdisciplinary collaboration between primary health care facilities.
- Open Access
- 14 July 2025
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 2,p. 171-175
Tuberculosis of peripheral lymph nodes in adolescents as a manifestation of a generalized specific process: Clinical case
Tuberculosis of peripheral lymph nodes is extremely rare, so when patients first contact a pediatrician due to enlargement of lymph nodes, it may be challenging to establish the correct diagnosis. To conduct a differential diagnosis between tuberculosis and nonspecific diseases, it is necessary to consider the medical history, paying special attention to the presence of contact with a patient with tuberculosis, and conducting a set of tests available to pediatricians and surgeons in general polyclinics and hospitals. The presented clinical case demonstrates the missed opportunities for timely diagnosis of tuberculosis in an adolescent, which led to the generalization of the specific process with involvement of peripheral lymph nodes and required several surgical interventions.
- 14 July 2025
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 2,p. 171-175
Open AccessTuberculosis of peripheral lymph nodes in adolescents as a manifestation of a generalized specific process: Clinical case
Tuberculosis of peripheral lymph nodes is extremely rare, so when patients first contact a pediatrician due to enlargement of lymph nodes, it may be challenging to establish the correct diagnosis. To conduct a differential diagnosis between tuberculosis and nonspecific diseases, it is necessary to consider the medical history, paying special attention to the presence of contact with a patient with tuberculosis, and conducting a set of tests available to pediatricians and surgeons in general polyclinics and hospitals. The presented clinical case demonstrates the missed opportunities for timely diagnosis of tuberculosis in an adolescent, which led to the generalization of the specific process with involvement of peripheral lymph nodes and required several surgical interventions.
- Open Access
- 4 April 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 141-148
Immunodiagnosis of tuberculosis infection in children and adolescents from socially vulnerable groups (review and comments)
Tuberculosis as a socially significant disease is the most important medical and social problem of the modern world, including our country. Children and adolescents from socially vulnerable groups require special attention. The high significance of the impact of social factors (standard of living and social protection of families, availability and effectiveness of medical care to the population, the degree of health literacy and cultural competence, migration processes) on the incidence of respiratory tuberculosis in children and adolescents is stressed. Particular attention is paid to the causes of MBT infection and tuberculosis in children and adolescents residing in new Russian regions: high probability of unidentified contact with a tuberculosis patient, often unsanitary living conditions, overcrowding, stress. The level of medical care and anti-tuberculosis measures carried out in these socially vulnerable groups is insufficient due to personal and impersonal reasons. This review is aimed to systematize knowledge about immunodiagnostics of tuberculosis infection in socially vulnerable groups of children and adolescents, to present the principal directive documents and comments on this issue for phthisiologists and paediatricians, taking into account interdisciplinary interaction. We conducted the analysis and systematization of data from current directive, methodological documents, articles, which present the concept of socially vulnerable groups, reflect approaches to the use of skin immunological tests and laboratory diagnostic tests based on the in vitro interferon gamma (IFN-γ) release by T-lymphocytes (IGRA tests) in mass-scale and selective screening in different socially vulnerable groups of children and adolescents. Non-routine situations on the use of immunodiagnostics in socially vulnerable groups are presented.
- 4 April 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 141-148
Open AccessImmunodiagnosis of tuberculosis infection in children and adolescents from socially vulnerable groups (review and comments)
Tuberculosis as a socially significant disease is the most important medical and social problem of the modern world, including our country. Children and adolescents from socially vulnerable groups require special attention. The high significance of the impact of social factors (standard of living and social protection of families, availability and effectiveness of medical care to the population, the degree of health literacy and cultural competence, migration processes) on the incidence of respiratory tuberculosis in children and adolescents is stressed. Particular attention is paid to the causes of MBT infection and tuberculosis in children and adolescents residing in new Russian regions: high probability of unidentified contact with a tuberculosis patient, often unsanitary living conditions, overcrowding, stress. The level of medical care and anti-tuberculosis measures carried out in these socially vulnerable groups is insufficient due to personal and impersonal reasons. This review is aimed to systematize knowledge about immunodiagnostics of tuberculosis infection in socially vulnerable groups of children and adolescents, to present the principal directive documents and comments on this issue for phthisiologists and paediatricians, taking into account interdisciplinary interaction. We conducted the analysis and systematization of data from current directive, methodological documents, articles, which present the concept of socially vulnerable groups, reflect approaches to the use of skin immunological tests and laboratory diagnostic tests based on the in vitro interferon gamma (IFN-γ) release by T-lymphocytes (IGRA tests) in mass-scale and selective screening in different socially vulnerable groups of children and adolescents. Non-routine situations on the use of immunodiagnostics in socially vulnerable groups are presented.
- Open Access
- 28 November 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 19,p. 178-186
Comorbid conditions in phthisiology: The basis of interdisciplinary collaboration between pediatricians and phthisiologists (literature review and commentaries)
Comorbid conditions in pediatric and adolescent phthisiology determine the need for interdisciplinary collaboration between healthcare professionals in different areas of expertise both at the stage of disease diagnosis and during tuberculosis treatment. This review is aimed to systematize the knowledge of pediatricians in different areas of expertise about comorbid conditions in tuberculosis (causes, risk factors for their development, options for timely diagnosis, impact of forced polypharmacy on the development of drug complications). The data of available methodological documents and published articles on the issue are systematized. The article presents groups at high risk for developing TB disease among patients with somatic pathology, the possibilities of modern diagnostic techniques based on a comprehensive medical examination with due account for the diagnostic algorithm and treatment regimen for a particular disease. If there is a reason to suspect tuberculosis in primary health care facilities and prior to prescribing immunosuppressive drugs, the minimum mandatory diagnostic examination in risk groups is set forth. The importance of key techniques for the detection and diagnosis of tuberculosis in children and adolescents including those with immunocompromised diseases is emphasized: Mantoux test using 5 tuberculin units (TU) of purified protein derivative (PPD)-L, a test with recombinant tuberculosis allergen (RTA), diagnostic tests assessing release of interferon gamma by T-lymphocytes in vitro during selective screening), computed tomography, detection of Mycobacterium tuberculosis in any diagnostic samples. Attention is paid to the impact of forced polypharmacy on the drug complications and treatment failures in patients with comorbidities, which requires collaboration between healthcare professionals in different areas of expertise to provide adequate selection of anti-tuberculosis therapy taking into account comorbidities. This approach to the management of patients with chronic somatic pathology allows for the prevention or early detection of tuberculosis.
- 28 November 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 19,p. 178-186
Open AccessComorbid conditions in phthisiology: The basis of interdisciplinary collaboration between pediatricians and phthisiologists (literature review and commentaries)
Comorbid conditions in pediatric and adolescent phthisiology determine the need for interdisciplinary collaboration between healthcare professionals in different areas of expertise both at the stage of disease diagnosis and during tuberculosis treatment. This review is aimed to systematize the knowledge of pediatricians in different areas of expertise about comorbid conditions in tuberculosis (causes, risk factors for their development, options for timely diagnosis, impact of forced polypharmacy on the development of drug complications). The data of available methodological documents and published articles on the issue are systematized. The article presents groups at high risk for developing TB disease among patients with somatic pathology, the possibilities of modern diagnostic techniques based on a comprehensive medical examination with due account for the diagnostic algorithm and treatment regimen for a particular disease. If there is a reason to suspect tuberculosis in primary health care facilities and prior to prescribing immunosuppressive drugs, the minimum mandatory diagnostic examination in risk groups is set forth. The importance of key techniques for the detection and diagnosis of tuberculosis in children and adolescents including those with immunocompromised diseases is emphasized: Mantoux test using 5 tuberculin units (TU) of purified protein derivative (PPD)-L, a test with recombinant tuberculosis allergen (RTA), diagnostic tests assessing release of interferon gamma by T-lymphocytes in vitro during selective screening), computed tomography, detection of Mycobacterium tuberculosis in any diagnostic samples. Attention is paid to the impact of forced polypharmacy on the drug complications and treatment failures in patients with comorbidities, which requires collaboration between healthcare professionals in different areas of expertise to provide adequate selection of anti-tuberculosis therapy taking into account comorbidities. This approach to the management of patients with chronic somatic pathology allows for the prevention or early detection of tuberculosis.
- Open Access
- 24 October 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 2,p. 204-208
Generalized tuberculosis with intestinal lesion in an adolescent. Case report
In the two recent decades a decrease in tuberculosis (TB) incidence has been observed worldwide, according to the World Health Organization, while the incidence of extrapulmonary TB, including TB of the intestine, is growing. Generally, diagnosis of TB in children and adolescents is difficult due to its subclinical course in a significant part of patients. A special diagnostic challenge is extrapulmonary TB, including abdominal TB. Abdominal TB has entered the top five most frequent manifestations of extrapulmonary TB along with TB of the peripheral lymph nodes, urogenital TB, bone and joint TB, and TB of the central nervous system. Lack of specific clinical signs of the disease results in late diagnosis of abdominal TB. We described a case of generalized TB with intestinal lesion in an adolescent. We detected mistakes in the follow-up of the female patient with double exposure to household TB, which resulted in late diagnosis of the disease. We demonstrated the challenges in diagnosing intestinal TB under the guise of appendicitis, which led to the development of complications – spilled peritonitis and abdominal abscess. The tactics of management of the female patient at high risk for developing bowel obstruction was represented. Interdisciplinary interactions with extrapulmonary TB specialists were accented for cases of generalized TB.
- 24 October 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 2,p. 204-208
Open AccessGeneralized tuberculosis with intestinal lesion in an adolescent. Case report
In the two recent decades a decrease in tuberculosis (TB) incidence has been observed worldwide, according to the World Health Organization, while the incidence of extrapulmonary TB, including TB of the intestine, is growing. Generally, diagnosis of TB in children and adolescents is difficult due to its subclinical course in a significant part of patients. A special diagnostic challenge is extrapulmonary TB, including abdominal TB. Abdominal TB has entered the top five most frequent manifestations of extrapulmonary TB along with TB of the peripheral lymph nodes, urogenital TB, bone and joint TB, and TB of the central nervous system. Lack of specific clinical signs of the disease results in late diagnosis of abdominal TB. We described a case of generalized TB with intestinal lesion in an adolescent. We detected mistakes in the follow-up of the female patient with double exposure to household TB, which resulted in late diagnosis of the disease. We demonstrated the challenges in diagnosing intestinal TB under the guise of appendicitis, which led to the development of complications – spilled peritonitis and abdominal abscess. The tactics of management of the female patient at high risk for developing bowel obstruction was represented. Interdisciplinary interactions with extrapulmonary TB specialists were accented for cases of generalized TB.
- Open Access
- 26 February 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 90-96
The vitamin D status and the levels of β1- and β2-defensins in children and adolescents with different forms of pulmonary TB
Introduction. The basic research demonstrated an important role of vitamin D in strengthening the immune response to Mycobacterium tuberculosis and proved its effect on the production of antimicrobial peptides. However, the correlation between the levels of vitamin D and defensins (β1 and β2) in children and adolescents with different forms of pulmonary TB was not studied.Aim. To study the correlation between the levels of vitamin D and β1- and β2-defensins in children and adolescents with different forms of pulmonary TB.Materials and methods. We carried out a prospective study of 75 patients with pulmonary TB aged 2–17 years (52 new cases and 23 retreatment cases) in 2021–2023. The levels of 25(OH)D and β1- and β2-defensins were determined at admission to hospital.Results. Out of 75 patients 2.7% had adequate levels of vitamin D (more than 30 ng/mL), 13.3% had insufficient levels of vitamin D (20 to 30 ng/mL), 34.7% had deficient levels of vitamin D (10 to 20 ng/mL), and 49.3% had severe deficiency of vitamin D (less than 10 ng/mL). We established a direct correlation between 25(OH)D and β1-defensin levels (p = 0.004766) and lack of correlation between 25(OH)D and β2-defensin levels. We discovered significant differences in the levels of 25(ОН)D and β1-defensin between new and retreatment cases: 13.10 ± 1.04 ng/mL and 8.74 ± 1.07 ng/mL (p = 0.004644) and 6.66 ± 0.79 ng/mL and 4.0 ± 0.85 ng/mL (p = 0.024816), respectively.Conclusion. The differences in the levels of calcidiol and β1-defensin between new and retreatment cases witness an impaired function of one of the innate non-specific immunity components during long-lasting advanced pulmonary TB in children and adolescents.
- 26 February 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 90-96
Open AccessThe vitamin D status and the levels of β1- and β2-defensins in children and adolescents with different forms of pulmonary TB
Introduction. The basic research demonstrated an important role of vitamin D in strengthening the immune response to Mycobacterium tuberculosis and proved its effect on the production of antimicrobial peptides. However, the correlation between the levels of vitamin D and defensins (β1 and β2) in children and adolescents with different forms of pulmonary TB was not studied.Aim. To study the correlation between the levels of vitamin D and β1- and β2-defensins in children and adolescents with different forms of pulmonary TB.Materials and methods. We carried out a prospective study of 75 patients with pulmonary TB aged 2–17 years (52 new cases and 23 retreatment cases) in 2021–2023. The levels of 25(OH)D and β1- and β2-defensins were determined at admission to hospital.Results. Out of 75 patients 2.7% had adequate levels of vitamin D (more than 30 ng/mL), 13.3% had insufficient levels of vitamin D (20 to 30 ng/mL), 34.7% had deficient levels of vitamin D (10 to 20 ng/mL), and 49.3% had severe deficiency of vitamin D (less than 10 ng/mL). We established a direct correlation between 25(OH)D and β1-defensin levels (p = 0.004766) and lack of correlation between 25(OH)D and β2-defensin levels. We discovered significant differences in the levels of 25(ОН)D and β1-defensin between new and retreatment cases: 13.10 ± 1.04 ng/mL and 8.74 ± 1.07 ng/mL (p = 0.004644) and 6.66 ± 0.79 ng/mL and 4.0 ± 0.85 ng/mL (p = 0.024816), respectively.Conclusion. The differences in the levels of calcidiol and β1-defensin between new and retreatment cases witness an impaired function of one of the innate non-specific immunity components during long-lasting advanced pulmonary TB in children and adolescents.